Abstract
Background
Pulmonary cryptococcosis (PC) is a fungal lung disease, and nodule/mass-type PC can exhibit imaging findings similar to lung cancer (LC). This study aimed to develop and externally test a new radiomics model based on the lesion and lesion-surrounding regions for distinguishing PC from LC.
Methods
In this retrospective study, patients with either PC or LC who underwent non-enhanced CT at four hospitals were included. A considerable number of radiomics features were extracted from the lesions and their surrounding regions (0–1 mm, 0–2 mm, and 0–3 mm). Ten methods were used to calculate Rad-score, followed by a 10-fold cross-validation. A combined model was developed by integrating Rad-score and clinical factors. The models were subsequently tested using external test sets and compared in terms of the area under the curve (AUC).
Results
A total of 391 patients, including 159 with PC and 232 with LC, were enrolled in this study. These patients were divided into three groups: training set, external test set 1, and external test set 2. In terms of Rad-score, linear SVC demonstrated the highest AUC of 0.901 in cross-validation. For the combined model, logistic regression showed the best predictive performance with an AUC of 0.946 in the cross-validation. A lesion-surrounding feature (0–3 mm) played the biggest role in both Rad-score and the combined model, accounting for the highest relative weight. In the external tests, the combined model exhibited higher AUCs (0.872 in the external test set 1, and 0.952 in the external test set 2) compared to Rad-score and the clinical model.
Conclusion
The combined model can aid in differentiating PC from LC, with the lesion-surrounding radiomics playing the most significant role.
Similar content being viewed by others
Data availability
The datasets generated during and analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- PC:
-
Pulmonary cryptococcosis
- LC:
-
lung cancer
- AUC:
-
the area under the curve
- VOI:
-
volume of interest
- ICC:
-
correlation coefficient
- pGGO:
-
pure ground-glass opacity
- SEN:
-
sensitivity
- SPE:
-
specificity
References
Chang CC, Sorrell TC, Chen SC. Pulmonary cryptococcosis. Semin Respir Crit Care Med. 2015;36(5):681–91.
Howard-Jones AR, Sparks R, Pham D, Halliday C, Beardsley J, Chen SC. Pulmonary Cryptococcosis J Fungi (Basel). 2022;8(11):1156.
Fang W, Fa Z, Liao W. Epidemiology of Cryptococcus and cryptococcosis in China. Fungal Genet Biol. 2015;78:7–15.
Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019;57(2):133–50.
Yamamura D, Xu J. Update on pulmonary cryptococcosis. Mycopathologia. 2021;186(5):717–28.
Marroni M, Pericolini E, Cenci E, Bistoni F, Vecchiarelli A. Functional defect of natural immune system in an apparent immunocompetent patient with pulmonary cryptococcosis. J Infect. 2007;54(1):e5–8.
Zhang Y, Chu Z, Yu J, Chen X, Liu J, Xu J, Huang C, Peng L. Computed tomography-based radiomics for identifying pulmonary cryptococcosis mimicking lung cancer. Med Phys. 2022;49(9):5943–52.
Zhao J, Sun L, Sun K, Wang T, Wang B, Yang Y, Wu C, Sun X. Development and validation of a Radiomics Nomogram for differentiating pulmonary cryptococcosis and lung adenocarcinoma in Solitary Pulmonary Solid Nodule. Front Oncol,2021,11:759840.
Hu B, Xia W, Piao S, Xiong J, Tang Y, Yu H, Tao G, Sun L, Shen M, Wagh A, Jaykel TJ, Zhang D, Li Y, Zhu L. A CT-based radiomics integrated model for discriminating pulmonary cryptococcosis granuloma from lung adenocarcinoma-a diagnostic test. Transl Lung Cancer Res. 2023;12(8):1790–801.
Yamazaki M, Yagi T, Tominaga M, Minato K, Ishikawa H. Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer. Br J Radiol. 2022;95(1140):20220374.
Shang Y, Chen W, Li G, Huang Y, Wang Y, Kui X, Li M, Zheng H, Zhao W, Liu J. Computed tomography-derived intratumoral and peritumoral radiomics in predicting EGFR mutation in lung adenocarcinoma. Radiol Med. 2023;128(12):1483–96.
Benchoufi M, Matzner-Lober E, Molinari N, Jannot AS, Soyer P. Interobserver agreement issues in radiology. Diagn Interv Imaging. 2020;101(10):639–41.
Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, McGinn T, Guyatt G. Discrimination and calibration of clinical prediction models: users’ guides to the Medical Literature. JAMA. 2017;318(14):1377–84.
Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak. 2006 Nov-Dec;26(6):565–74.
Iyer KR, Revie NM, Fu C, Robbins N, Cowen LE. Treatment strategies for cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol. 2021;19(7):454–66.
Yang D, Yu L, Luo J, Shen J, Wang D, Kuang P, Fu G. Characterization of clinical and CT manifestations of pulmonary cryptococcosis with consolidation. Arch Iran Med. 2021;24(6):508–11.
Choe YH, Moon H, Park SJ, Kim SR, Han HJ, Lee KS, Lee YC. Pulmonary cryptococcosis in asymptomatic immunocompetent hosts. Scand J Infect Dis. 2009;41(8):602–7.
Severo CB, Bruno RM, Oliveira Fde M, Teixeira PZ, Hochhegger B, Severo LC. A case of miliary pulmonary cryptococcosis and review of literature. Mycopathologia. 2015;179(3–4):313–5.
Wang D, Wu C, Gao J, Zhao S, Ma X, Wei B, Feng L, Wang Y, Xue X. Comparative study of primary pulmonary cryptococcosis with multiple nodules or masses by CT and pathology. Exp Ther Med. 2018;6(6):4437–44.
Deng H, Zhang J, Li J, Wang D, Pan L, Xue X. Clinical features and radiological characteristics of pulmonary cryptococcosis. J Int Med Res. 2018;46(7):2687–95.
Shi W, Zhou L, Peng X et al. HIV-infected patients with opportunistic pulmonary infections misdiagnosed as lung cancers: the clinicoradiologic features and initial application of CT radiomics. J Thorac Dis, 2019, 11(6):2274–86.
Zhang ZX, Mu XY, Yu J, Guan CS, Chen BD, Xie RM. Establishment and evaluation of a CT-based radiomic model for AIDS-associated pulmonary cryptococcosis. BMC Med Imaging. 2022;22(1):185.
Funding
This work was supported by the Key Research & Development Project of Science and Technology Department of Sichuan Province (Grant No. 2021YFS0142), and the National Natural Science Foundation of China [Grant No. 81601462].
Author information
Authors and Affiliations
Contributions
LQP and YCZ conceived and designed the study. ZGC, ML, TMD, JXX and CCH collected the data, performed the statistical analyses, and drafted the manuscript. LQP revised the manuscript critically for important content. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Authors Jingxu Xu and Chencui Huang are employed by the company Beijing Deepwise & League of PHD Technology Co., Ltd. The remaining authors declare no conflicts-of-interest related to this article.
Ethical approval and consent to participate
This study followed the ethical guidelines of the Declaration of Helsinki, and was approved by the institutional review boards of West China Hospital, Sichuan University, China (2019-062).
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, Y., Chu, Z., Li, M. et al. CT radiomics including lesion-surrounding regions for distinguishing pulmonary cryptococcosis from lung cancer. Chin J Acad Radiol (2024). https://doi.org/10.1007/s42058-024-00152-1
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s42058-024-00152-1